ClinicalTrials.Veeva

Menu

Study of Minirin Melt® in Adult Patients With Nocturia

Ferring logo

Ferring

Status

Terminated

Conditions

Nocturia

Treatments

Drug: Desmopressin

Study type

Observational

Funder types

Industry

Identifiers

Details and patient eligibility

About

Observation of safety and efficacy of Minirin Melt® in adult patients with nocturia

Enrollment

835 patients

Sex

All

Ages

19 to 65 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Adult aged between 19 and 65 years
  • Patients having nocturia
  • Decision made to prescribe Minirin Melt according to prescription information
  • Willingness and ability to provide written informed consent

Exclusion criteria

  • When patients have habitual or psychogenic polydipsia (resulting in a urine production exceeding 40ml/kg/24hours)
  • When patients have a history of known or suspected cardiac insufficiency and other conditions requiring treatment with diuresis
  • When patients have moderate and severe renal insufficiency (creatinine clearance below 50ml/min)
  • When patients have known hyponatremia
  • When patients have secretion Syndrome of Inappropriate Antidiuretic Hormone Secretion (SIADH)
  • When patients have hypersensitivity to the active substances or to any of the excipients

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems